184 related articles for article (PubMed ID: 239185)
41. Chelation in metal intoxication. XXIX: Alpha-mercapto-beta-aryl acrylic acids as antidotes to mercury (II) toxicity.
Kachru DN; Khandelwal S; Sharma BL; Tandon SK
Pharmacol Toxicol; 1989 Feb; 64(2):182-4. PubMed ID: 2755917
[TBL] [Abstract][Full Text] [Related]
42. The outbreak of Minamata disease (methyl mercury poisoning) in cats on Northwestern Ontario reserves.
Takeuchi T; D'Itri FM; Fischer PV; Annett CS; Okabe M
Environ Res; 1977 Apr; 13(2):215-28. PubMed ID: 862594
[No Abstract] [Full Text] [Related]
43. Effect of selenite on the toxicity of dietary methyl mercury and mercuric chloride in the rat.
Potter S; Matrone G
J Nutr; 1974 May; 104(5):638-47. PubMed ID: 4856782
[No Abstract] [Full Text] [Related]
44. Role of 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning.
Graziano JH
Med Toxicol; 1986; 1(3):155-62. PubMed ID: 3023784
[No Abstract] [Full Text] [Related]
45. Poisoning from heavy metals (mercury, lead, and cadmium).
Chisolm JJ
Pediatr Ann; 1980 Dec; 9(12):458-68. PubMed ID: 7005844
[No Abstract] [Full Text] [Related]
46. Post-mortem findings and clinical signs of dimethyl mercury poisoning in man.
Pazderová J; Jirásek A; Mráz M; Pechan J
Int Arch Arbeitsmed; 1974; 33(4):323-8. PubMed ID: 4466816
[No Abstract] [Full Text] [Related]
47. 203-Hg excretion and tissue distribution in Holstein calves following single tracer intravenous doses of methyl mercury chloride or mercuric chloride.
Stake PE; Neathery MW; Miller WJ; Gentry RP
J Anim Sci; 1975 Apr; 40(4):720-6. PubMed ID: 1141059
[No Abstract] [Full Text] [Related]
48. The enigma of parkinsonism in chronic borderline mercury intoxication, resolved by challenge with penicillamine.
Finkelstein Y; Vardi J; Kesten MM; Hod I
Neurotoxicology; 1996; 17(1):291-5. PubMed ID: 8784840
[TBL] [Abstract][Full Text] [Related]
49. Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity.
Miller AL
Altern Med Rev; 1998 Jun; 3(3):199-207. PubMed ID: 9630737
[TBL] [Abstract][Full Text] [Related]
50. Protection of mice against the lethal effects of sodium arsenite by 2,3 dimercapto-1-propane-sulfonic acid and dimercaptosuccinic acid.
Tadlock CH; Aposhian HV
Biochem Biophys Res Commun; 1980 May; 94(2):501-7. PubMed ID: 6249288
[No Abstract] [Full Text] [Related]
51. [Acrodynia (comparative study of various chelating agents; curable agranulocytosis during treatment by penicillamine)].
François R; Germain D; Pellet H; Moreau P; Pouillaude JM; Collard N
Pediatrie; 1967; 22(3):341-6. PubMed ID: 5607348
[No Abstract] [Full Text] [Related]
52. The relative effectiveness of some chelating agents as antidotes in acute cadmium poisoning.
Jones MM; Weaver AD; Weller WL
Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):581-8. PubMed ID: 216066
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of the chelating action of methicillin in prolonged experimental metallic mercury poisoning.
Lyle WH
Br J Ind Med; 1987 Jan; 44(1):71. PubMed ID: 3814539
[No Abstract] [Full Text] [Related]
54. The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury.
Rooney JP
Toxicology; 2007 May; 234(3):145-56. PubMed ID: 17408840
[TBL] [Abstract][Full Text] [Related]
55. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on tissue and urine mercury levels following prolonged methylmercury exposure in rats.
Pingree SD; Simmonds PL; Woods JS
Toxicol Sci; 2001 Jun; 61(2):224-33. PubMed ID: 11353131
[TBL] [Abstract][Full Text] [Related]
56. [Incorporation of metallic mercury].
Westermann KH; Staib AH; Tribulowski S
Dtsch Gesundheitsw; 1971 Jan; 26(3):126-9. PubMed ID: 5096026
[No Abstract] [Full Text] [Related]
57. Acute and subchronic methylmercury toxicosis in the rat.
Diamond SS; Sleight SD
Toxicol Appl Pharmacol; 1972 Oct; 23(2):197-207. PubMed ID: 4116380
[No Abstract] [Full Text] [Related]
58. Clinical uses of metal-binding drugs.
Chenoweth MB
Clin Pharmacol Ther; 1968; 9(3):365-87. PubMed ID: 4984845
[No Abstract] [Full Text] [Related]
59. A methylmercury toxicity model to test for possible adverse effects resulting from chelating agent therapy.
Kostyniak PJ; Soiefer AI
J Appl Toxicol; 1984 Aug; 4(4):206-10. PubMed ID: 6092450
[TBL] [Abstract][Full Text] [Related]
60. The present status of chelating agents in medicine.
May PM; Bulman RA
Prog Med Chem; 1983; 20():225-336. PubMed ID: 6356226
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
